Futura Medical (LON:FUM) Stock Price Up 10.9% – What’s Next?

Shares of Futura Medical plc (LON:FUM) rose 10.9% during mid-day trading on Thursday . The company traded as high as GBX 0.52 and last traded at GBX 0.51. 5,393,217 shares traded hands during mid-day trading, a decline of 37% from the average daily volume of 8,544,223 shares. The stock had previously closed at GBX 0.46.

Futura Medical Trading Up 9.4%

The company’s 50-day simple moving average is GBX 0.70 and its 200 day simple moving average is GBX 1.04. The stock has a market cap of £3.24 million, a P/E ratio of -0.20 and a beta of 0.02.

Futura Medical (LON:FUM) last announced its earnings results on Wednesday, April 29th. The company reported GBX (2.78) earnings per share for the quarter. The business had revenue of GBX 170 million during the quarter. Futura Medical had a negative return on equity of 310.00% and a negative net margin of 534.62%. Research analysts anticipate that Futura Medical plc will post 2.8486672 earnings per share for the current fiscal year.

About Futura Medical

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.